Please use this identifier to cite or link to this item:
http://earsiv.odu.edu.tr:8080/xmlui/handle/11489/1980
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Aytemir, Kudret | - |
dc.contributor.author | Bayrak, Tulin | - |
dc.contributor.author | Canpolat, Ugur | - |
dc.contributor.author | Karabulut, Erdem | - |
dc.contributor.author | Kaya, Ergun Baris | - |
dc.contributor.author | Oto, Ali | - |
dc.contributor.author | Ozer, Necla | - |
dc.contributor.author | Ozkan, Adem | - |
dc.contributor.author | Ozkara, Asuman | - |
dc.contributor.author | Sunman, Hamza | - |
dc.contributor.author | Tokgozoglu, Lale | - |
dc.contributor.author | Yorgun, Hikmet | - |
dc.date.accessioned | 2022-08-16T11:39:51Z | - |
dc.date.available | 2022-08-16T11:39:51Z | - |
dc.date.issued | 2018 | - |
dc.identifier.uri | http://doi.org/10.5603/CJ.a2017.0111 | - |
dc.identifier.uri | http://earsiv.odu.edu.tr:8080/xmlui/handle/11489/1980 | - |
dc.description.abstract | Background: Several studies have investigated the effects of cardiac resynchronization therapy (CRT) on heart failure (HF), but none have evaluated the pathophysiological pathways involved in a single group of patients. Therefore, this study aims to assess the long-term effects of CRT on six different pathophysiological pathways involved in the process of HF by the use of surrogate biomarkers. Methods: In a group 44 patients with HF, six groups of biomarkers were measured, both at baseline and 1 year after CRT implantation: inflammation (interleukin [IL]-4, IL-6, tumor necrosis factor [TNF]-alpha, high sensitive C-reactive protein [hsCRP]); oxidative stress (myeloperoxidase [MPO], oxidized low-density lipoprotein [oxLDL], uric acid); extracellular matrix (ECM) remodeling (matrix metalloproteinase [MMP]-2 and -9, galectin-3, procollagen III N-terminal propeptide [prokol-3NT]); neurohormonal pathways (endothelin-1, chromogranin-A); myocyte injury (troponin T, creatine kinase MB fraction [CK-MB]), myocyte stress (B-type natriuretic peptide [BNP]). CRT responders were defined as patients with >= 15% reduction in left ventricular end-systolic volume at 12 months post-CRT. Results: At 1-year follow-up, 72.7% (n = 32) of the patients were categorized as CRT responders. In these patients, the levels of IL-6, MPO, oxLDL, MMP-2, galectin-3, troponin T, and BNP were significantly reduced as compared to baseline values. While the biomarkers for myocyte stress (effect size = 0.357; p = 0.001), ECM remodeling (effect size = 0.343; p = 0.015) and oxidative stress (effect size = 0.247; p = 0.039) showed a significant change in the CRT responders during follow-up, the biomarkers for other pathophysiological pathways did not show a significant alteration. Conclusions: In the present study, a significant reduction was only observed in the biomarkers of myocardial stress, ECM remodeling, and oxidative stress among all the CRT responder subjects. | en_US |
dc.language.iso | eng | en_US |
dc.publisher | VIA MEDICA, UL SWIETOKRZYSKA 73, 80-180 GDANSK, POLAND | en_US |
dc.relation.isversionof | 10.5603/CJ.a2017.0111 | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | cardiac resynchronization therapy; responder; pathophysiology; biomarkers | en_US |
dc.title | Evaluating the effects of cardiac resynchronization therapy on pathophysiological pathways of heart failure using surrogate biomarkers | en_US |
dc.type | article | en_US |
dc.relation.journal | CARDIOLOGY JOURNAL | en_US |
dc.contributor.department | Ordu Üniversitesi | en_US |
dc.contributor.authorID | 0000-0002-4250-1706 | en_US |
dc.identifier.volume | 25 | en_US |
dc.identifier.issue | 1 | en_US |
dc.identifier.startpage | 42 | en_US |
dc.identifier.endpage | 51 | en_US |
Appears in Collections: | Temel Tıp Bilimleri |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.